Werner Kiefer

1.5k total citations · 1 hit paper
28 papers, 1.3k citations indexed

About

Werner Kiefer is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Werner Kiefer has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in Werner Kiefer's work include Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Werner Kiefer is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Werner Kiefer collaborates with scholars based in Germany, Brazil and Switzerland. Werner Kiefer's co-authors include Gerd Dannhardt, Stefan Laufer, Bernd L. Fiebich, J. Augustín, Tanja Schirmeister, Jochen Bodem, Maria Fátima das Graças Fernandes da Silva, Lorena Ramos Freitas de Sousa, João Batista Fernandes and Paulo C. Vieira and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Infection and Immunity.

In The Last Decade

Werner Kiefer

26 papers receiving 1.2k citations

Hit Papers

Cyclooxygenase inhibitors – current status and future pro... 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner Kiefer Germany 14 618 478 251 157 86 28 1.3k
Maria Koufaki Greece 20 749 1.2× 254 0.5× 329 1.3× 65 0.4× 122 1.4× 46 1.2k
Eleni Pontiki Greece 27 1.2k 1.9× 343 0.7× 464 1.8× 270 1.7× 49 0.6× 79 2.2k
Barij Nayan Sinha India 25 637 1.0× 278 0.6× 550 2.2× 160 1.0× 38 0.4× 108 1.6k
Min Chu United States 23 536 0.9× 948 2.0× 882 3.5× 42 0.3× 51 0.6× 85 1.9k
Raju S. Kanumuri India 23 424 0.7× 245 0.5× 492 2.0× 164 1.0× 264 3.1× 99 1.7k
Lawrence F. Colwell United States 19 398 0.6× 106 0.2× 555 2.2× 67 0.4× 55 0.6× 33 1.2k
Fabio Sparatore Italy 26 1.6k 2.6× 232 0.5× 846 3.4× 136 0.9× 39 0.5× 137 2.4k
João Xavier de Araújo‐Júnior Brazil 25 467 0.8× 152 0.3× 554 2.2× 253 1.6× 102 1.2× 104 1.8k
Zhili Zuo China 25 378 0.6× 460 1.0× 796 3.2× 115 0.7× 100 1.2× 101 1.8k
Juan A. Páez Spain 19 415 0.7× 414 0.9× 425 1.7× 94 0.6× 33 0.4× 72 1.2k

Countries citing papers authored by Werner Kiefer

Since Specialization
Citations

This map shows the geographic impact of Werner Kiefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Kiefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Kiefer more than expected).

Fields of papers citing papers by Werner Kiefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Kiefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Kiefer. The network helps show where Werner Kiefer may publish in the future.

Co-authorship network of co-authors of Werner Kiefer

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Kiefer. A scholar is included among the top collaborators of Werner Kiefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Kiefer. Werner Kiefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimmermann, Robert A., et al.. (2024). Dual Strategy to Design New Agents Targeting Schistosoma mansoni: Advancing Phenotypic and SmCB1 Inhibitors for Improved Efficacy. ACS Infectious Diseases. 10(5). 1664–1678.
2.
Hammerschmidt, Stefan, Fabian Barthels, Fabian Elgner, et al.. (2019). Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases. Journal of Medicinal Chemistry. 62(24). 11359–11382. 70 indexed citations
3.
Kiefer, Werner, et al.. (2019). Identification of a potential allosteric site of Golgi α-mannosidase II using computer-aided drug design. PLoS ONE. 14(5). e0216132–e0216132. 6 indexed citations
4.
Kiefer, Werner, et al.. (2018). New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8. European Journal of Medicinal Chemistry. 156. 587–597. 14 indexed citations
5.
Sousa, Lorena Ramos Freitas de, Hongmei Wu, Liliane Nebo, et al.. (2015). Natural products as inhibitors of recombinant cathepsin L of Leishmania mexicana. Experimental Parasitology. 156. 42–48. 25 indexed citations
6.
Sousa, Lorena Ramos Freitas de, Hongmei Wu, Liliane Nebo, et al.. (2014). Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies. Bioorganic & Medicinal Chemistry. 23(3). 466–470. 123 indexed citations
7.
Kiefer, Werner & Gerd Dannhardt. (2005). COX-2 inhibition and pain management: a review summary. Expert Review of Clinical Immunology. 1(3). 431–442. 5 indexed citations
8.
Kiefer, Werner & Gerd Dannhardt. (2004). Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2. Current Medicinal Chemistry. 11(24). 3147–3161. 37 indexed citations
9.
Banwell, Martin G., Anna Bezos, Satish Chand, et al.. (2003). Convergent synthesis and preliminary biological evaluations of the stilbenolignan (±)-aiphanol and various congeners. Organic & Biomolecular Chemistry. 1(14). 2427–2429. 20 indexed citations
10.
Weigmann, Harald, et al.. (2001). Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 759(1). 63–71. 56 indexed citations
11.
Dannhardt, Gerd & Werner Kiefer. (2001). Cyclooxygenase inhibitors – current status and future prospects. European Journal of Medicinal Chemistry. 36(2). 109–126. 574 indexed citations breakdown →
12.
Dannhardt, Gerd, et al.. (2000). The pyrrole moiety as a template for COX-1/COX-2 inhibitors. European Journal of Medicinal Chemistry. 35(5). 499–510. 163 indexed citations
13.
Werner, Wolfgang, Gottfried Blaschke, Werner Kiefer, et al.. (2000). Effect of Flavonol Derivatives on the Carrageenin-Induced Paw Edema in the Rat and Inhibition of Cyclooxygenase-1 and 5-Lipoxygenasein Vitro. Archiv der Pharmazie. 333(7). 205–210. 14 indexed citations
14.
Werner, Wolfgang, Gottfried Blaschke, Werner Kiefer, et al.. (2000). Effect of Flavonol Derivatives on the Carrageenin-Induced Paw Edema in the Rat and Inhibition of Cyclooxygenase-1 and 5-Lipoxygenase in Vitro. Archiv der Pharmazie. 333(7). 205–210. 1 indexed citations
15.
Laufer, Stefan, et al.. (1997). Synthesis and Evaluation of a Novel Series of Pyrrolizine Derivatives as Dual Cyclooxygenase‐1 and 5‐Lipoxygenase Inhibitors. Archiv der Pharmazie. 330(9-10). 307–312. 24 indexed citations
17.
Laufer, Stefan, J. Augustín, Gerd Dannhardt, & Werner Kiefer. (1994). (6,7-Diaryldihydropyrrolizin-5-yl)acetic Acids, a Novel Class of Potent Dual Inhibitors of Both Cyclooxygenase and 5-Lipoxygenase. Journal of Medicinal Chemistry. 37(12). 1894–1897. 100 indexed citations
19.
Kiefer, Werner, G Schmidt, Ben Jann, & Klaus Jann. (1976). Genetic Transfer of Salmonella O Antigens to Escherichia coli 08. Journal of General Microbiology. 92(2). 311–324. 11 indexed citations
20.
Schmidt, G & Werner Kiefer. (1974). [Salmonella-E. coli hybrid: characterization and immunological efficacy].. PubMed. 227(1-4). 257–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026